EMAS position statement: Fertility preservation

Maturitas. 2014 Jan;77(1):85-9. doi: 10.1016/j.maturitas.2013.10.010. Epub 2013 Oct 25.


Introduction: The increasing incidence of malignant diseases that often require gonadotoxic treatment and the tendency to become a parent later in life result in an increased need for fertility preservation.

Aims: The aim of this position statement is to provide and critically appraise evidence on available options for fertility preservation in both pre-pubertal and post-pubertal men and women.

Materials and methods: Literature review and consensus of expert opinion.

Results and conclusions: Fertility preservation should be a priority when treating children or adults of reproductive age with agents that may have hazardous effects on the reproductive system. Gonadotoxicity should be kept at a minimum. If gonadotoxic treatment has to be used, methods of fertility preservation should be discussed, as early as possible.

Keywords: Embryo cryopreservation; Fertility preservation; Gonadotoxicity; Oocyte cryopreservation; Sperm cryopreservation.

MeSH terms

  • Adult
  • Child
  • Consensus
  • Female
  • Fertility Preservation* / methods
  • Fertility*
  • Humans
  • Infertility, Female / etiology
  • Infertility, Female / prevention & control*
  • Infertility, Male / etiology
  • Infertility, Male / prevention & control*
  • Male
  • Reproduction* / drug effects
  • Reproduction* / radiation effects
  • Societies, Medical